 |
|
|
|
|
 |
Last Updated: Nov 2, 2013 - 11:52:55 AM |
Latest Research
:
Cancer
:
Lung
Tamoxifen reduces mortality rate in lung cancer
A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual's risk of death from lung cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study supports the hypothesis that there is a hormonal influence on lung cancer and that estrogen levels play a role in lung cancer patients' prognosis.
Jan 24, 2011 - 4:21:39 PM
|
Latest Research
:
Cancer
:
Lung
Lung Cancer risk greater in tuberculosis patients
A study published in the January issue of the Journal of Thoracic Oncology provides compelling evidence of increased lung cancer risk among people with tuberculosis.
Jan 2, 2011 - 11:55:15 PM
|
Latest Research
:
Cancer
:
Lung
Genes to identify patients who would benefit from chemotherapy
Cancer researchers have identified six gene markers present in early stage non-small cell lung cancer (NSCLC) that show promise in helping oncologists better identify which tumors will relapse after curative surgery, according to a study presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology.
Dec 10, 2010 - 6:03:31 AM
|
Latest Research
:
Cancer
:
Lung
First-line treatment with erlotinib improved progression-free survival in advanced lung cancer
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Oct 10, 2010 - 5:57:21 AM
|
Latest Research
:
Cancer
:
Lung
Genetic variation-Lung cancer drugs work better in the Japanese than in the Americans
Last year, a groundbreaking international project found that a group of Japanese patients with advanced non-small cell lung cancer survived longer âand had a higher rate of side effects â than U.S. patients with the same diagnosis,.when both groups were given two well-known drugs for the disease.
Now, a follow-up study suggests the reasons appear to lie in subtle variations in certain genes that govern how the body metabolizes chemotherapy drugs.
Jun 3, 2007 - 3:30:28 AM
|
Latest Research
:
Cancer
:
Lung
Ireland Cancer Center researchers advance lung cancer treatment
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents. Led by Balazs Halmos, MD, hematologist/oncologist with the Ireland Cancer Center, the research team followed up on their previous study, published in the New England Journal of Medicine, which found that lung cancer cells can become resistant to novel targeted agents, such as Tarceva (erlotinib), a medication in widespread use for non-small-cell lung cancer (NSCLC).
Apr 23, 2007 - 12:39:18 PM
|
Latest Research
:
Radiology
Lung cancer screening regimen provides opportunity for cure
Annual computed tomography (CT) screening identifies a high proportion of patients with early-stage lung cancer, according to the latest findings of the New York Early Lung Cancer Action Project (NY-ELCAP) published in the April issue of the journal Radiology.
Mar 27, 2007 - 1:10:05 AM
|
Latest Research
:
Cancer
:
Lung
MEK inhibitors may be beneficial for lung cancer containing mutations in the BRaf gene
In a new report in the February 15th issue of G&D, Dr. Martin McMahon (UCSF) and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
Feb 13, 2007 - 3:38:35 AM
|
Latest Research
:
Cancer
:
Lung
Potential solution to cetuximab-resistance in lung cancers
Antibodies that selectively bind and destroy cancer cells represent some of the most promising cancer therapy approaches being developed today. Several of these antibodies have reached the market, including cetuximab, which targets the epidermal growth factor receptor (EGFR) protein. However, a study conducted at the Dana-Farber Cancer Institute and the Ludwig Center at Dana-Farber/Harvard Medical School now suggests that antibodies binding a particular protein conformation, caused by hyperactivation, might have distinct therapeutic advantages over antibodies, like cetuximab, that bind to wild-type (normal) target proteins.
Jan 28, 2007 - 4:06:45 AM
|
Latest Research
:
Cancer
:
Lung
Gene Expression Profiling Not Quite Perfected in Predicting Lung Cancer Prognosis
While there have been significant advances in the use of gene expression profiling to assess a cancer prognosis, a Mayo Clinic review and analysis of existing lung cancer studies shows that this technology has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.
Nov 17, 2006 - 1:31:00 PM
|
Latest Research
:
Cancer
:
Lung
I-ELCAP study: Lung cancer can be detected early with annual low-dose CT screening
Lung cancer can be detected at its very earliest stage in 85 percent of patients using annual low-dose CT screening, and when followed by prompt surgical removal, the 10-year survival rate is 92 percent. These results, to be reported in the October 26 New England Journal of Medicine, would dramatically decrease the number of deaths from lung cancer the number one cause of cancer deaths among both men and women in the U.S.
Oct 26, 2006 - 7:24:00 PM
|
Latest Research
:
Cancer
:
Lung
Key to lung cancer chemotherapy resistance revealed
Scientists at Johns Hopkins have discovered how taking the brakes off a "detox" gene causes chemotherapy resistance in a common form of lung cancer. Products made by a gene called NRF2 normally protect cells from environmental pollutants like cigarette smoke and diesel exhaust by absorbing the materials and pumping them out of the cell. Another gene called KEAP1 encodes products that stop this cleansing process. But lung cancer cells sabotage the expression of these same genes to block assault from chemotherapy drugs.
Oct 11, 2006 - 5:36:00 AM
|
Latest Research
:
Cancer
:
Lung
3D-CRT brings hope for inoperable lung cancers
Modern three-dimensional radiation therapy has been proven to be more successful at curing lung cancer than older two-dimensional radiation therapy for some patients with early stage lung cancer, according to a new study in the September 1, 2006 edition of the International Journal of Radiation Oncology * Biology * Physics, the official journal of the American Society for Therapeutic Radiology and Oncology (ASTRO).
Sep 1, 2006 - 5:34:00 PM
|
Latest Research
:
Cancer
:
Lung
Sunitinib Malate shows promise against advanced form of lung cancer
Results of a multi-center clinical study of a drug currently approved for treatment of kidney cancer indicate that it may also be effective for people with recurrent and advanced lung cancer.
Jun 5, 2006 - 4:31:00 PM
|
Latest Research
:
Cancer
:
Lung
Tarceva-Celebrex Combination therapy shows promising results in advanced lung cancer
An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported. Pairing the targeted therapy Tarceva with the anti-inflammatory drug Celebrex increased response rates in lung cancer patients by about three-fold, said Dr. Karen Reckamp, an assistant professor of hematology/oncology and lead author of the study. The research appears in the June 1 issue of Clinical Cancer Research, the peer-reviewed journal of the American Association of Cancer Research.
Jun 1, 2006 - 1:41:00 PM
|
Latest Research
:
Cancer
:
Lung
Lung cancer susceptibility runs in families - Study
Studying thousands of people, researchers at The University of Texas M. D. Anderson Cancer Center have documented a 25 percent increased risk of developing one of a number of cancers in first-degree relatives of lung cancer patients who have never smoked compared to families of people who neither smoke nor have lung cancer.
Apr 3, 2006 - 6:59:00 AM
|
Latest Research
:
Cancer
:
Lung
Do Variants in the GST Detoxification Genes Affect the Risk of Lung Cancer?
By the year 2020, global deaths from noncommunicable diseases are expected to increase by 77%. The projected rise is mainly due to the aging of the population and to an increase in the numbers of people exposed to tobacco. While antismoking campaigns have met with some success in developed countries, the tobacco epidemic is growing in many of the world's developing and most populous countries. Tobacco (a major risk factor not only for lung cancer but also for chronic obstructive pulmonary diseases such as emphysema) is expected to kill more people than any single disease, surpassing even the HIV epidemic.
Mar 8, 2006 - 5:11:00 AM
|
Latest Research
:
Cancer
:
Lung
Tumor diameter - an important prognostic indicator for curability
Smaller tumors in the lungs appear to be less likely to have spread than larger tumors among patients with asymptomatic lung cancer, suggesting that early screening may be useful in detecting cancers that are still curable, according to a new article in the February 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Feb 15, 2006 - 2:55:00 PM
|
Latest Research
:
Cancer
:
Lung
Palliative radiation can cure some NSCLC
About one in a hundred patients with apparently incurable non-small cell lung cancer (NSCLC) survive five or more years after being given relatively small doses of radiation therapy (RT) meant to ease symptoms, according to a new study. Published in the March 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study says a new subset of patients with NSCLC appears to have disease that is curable with minimal therapy, and may explain occasional cures attributed to unconventional therapies or faith healing.
Jan 23, 2006 - 4:08:00 PM
|
Latest Research
:
Cancer
:
Lung
Bexarotene shows promise in lung cancer treatment
The ideal substance to prevent cancer would block tumor growth without causing unpleasant or dangerous side effects. Researchers at Washington University School of Medicine in St. Louis now report that a compound related to vitamin A shows promise in preventing or slowing tumor growth in mice prone to lung cancer.
Jan 18, 2006 - 5:52:00 PM
|
Latest Research
:
Cancer
:
Lung
Aromatase inhibitors may slow growth of lung cancer as well
A medical student conducting research on a Howard Hughes Medical Institute (HHMI) fellowship and colleagues have managed to stop the growth of human lung cancer cells in mice with a class of breast cancer drugs called aromatase inhibitors. The studies are reported in the December 15, 2005 issue of the journal Cancer Research. It was a natural progression of the work that had already been done linking estrogen and lung cancer, said Olga Weinberg, who delayed her fourth year at Vanderbilt University School of Medicine to work on the project. The findings suggest a new way to treat lung cancer in women - a group whose death rate from the disease is surging.
Dec 15, 2005 - 3:48:00 PM
|
Latest Research
:
Cancer
:
Lung
Women with Lung Cancer Live Longer than Men
Women with lung cancer are living longer than men, even when the disease is untreated. A new study presented at CHEST 2005, the 71st annual international scientific assembly of the of Chest Physicians (ACCP), found that in patients receiving treatment for lung cancer, women had significantly better survival rates than men. However, in untreated patients, women also had a 21 percent decreased risk of death as compared with men, leading researchers to believe lung cancer in women has a different biologic behavior and natural history than in men.
Nov 4, 2005 - 10:01:00 PM
|
Latest Research
:
Cancer
:
Lung
Epidermal Growth Factor Receptor (EGFR) Mutations and Lung Cancer
Tyrosine kinases of the epidermal growth factor receptor (EGFR) family are frequently mutated in human cancers. Mutations in the tyrosine kinase domain of EGFR (encoded by exons 18â24) have mostly been found in lung cancers. Some, but not all, lung cancers carrying such mutations are responsive to treatment with small-molecule EGFR inhibitors, including the two FDA-approved drugs erlotinib and gefitinib.
Oct 7, 2005 - 6:56:00 PM
|
Latest Research
:
Cancer
:
Lung
Number of Cigarettes Determine Extent of Lung Cancer Risk
Heavy smokers (more than 15 cigarettes per day) can reduce their risk of lung cancer if they decrease smoking by 50 percent, according to a study in the September 28 issue of JAMA. Lung cancer remains the leading cause of cancer death worldwide, and an estimated 90 percent of lung cancer cases are tobacco-related, according to background information in the article. Despite efforts to prevent people from beginning smoking and to encourage smoking cessation, the overall prevalence of cigarette smoking is still high and many smokers are unable or unwilling to completely quit.
Sep 28, 2005 - 1:43:00 PM
|
Latest Research
:
Cancer
:
Lung
Dietary Phytoestrogens Reduce Risk of Lung Cancer
A diet higher in plant-derived compounds known as phytoestrogens is linked with a lower lung cancer risk, according to a study in the September 28 issue of JAMA. Phytoestrogens are plant-derived nonsteroidal compounds found in soy products, grains, carrots, spinach, broccoli, and other fruits and vegetables, according to background information in the article. Phytoestrogens have been shown to have a protective effect against some solid tumors, but there has been little epidemiologic research focused on dietary intake of phytoestrogens and lung cancer risk.
Sep 28, 2005 - 1:32:00 PM
|
Latest Research
:
Cancer
:
Lung
PGT202 trial demonstrated survival advantage with paclitaxel poliglumex
At a presentation at the UBS Global Life Sciences Conference, Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX: CTIC) presented new results from a recently completed phase II clinical trial of XYOTAX in the first-line treatment of men and women with advanced non-small cell lung cancer (NSCLC).
Sep 28, 2005 - 1:01:00 PM
|
Latest Research
:
Cancer
:
Lung
Epigenetic Activity Silences Rb2/P130 Gene In Lung Cancer
The attaching of methyl--or chemical--groups onto DNA sequences within the tumor suppressing gene Rb2/p130 can cause the gene to cease functioning in non-small lung cancer cells (NSLC) and retinoblastoma cells, researchers at Temple University's Sbarro Institute for Cancer Research and Molecular Medicine and Italy's University of Siena have discovered.
Sep 14, 2005 - 2:20:00 AM
|
Latest Research
:
Cancer
:
Lung
Better Combination Therapy for Patients with Locally Advanced Lung Cancer
While researchers have learned in the last decade that combining chemotherapy with radiation is better than radiation alone for treating non-small cell lung cancer patients with locally advanced disease cancer confined to the lungs finding the right combination of drugs and the best timing of treatment has been tricky.
Sep 4, 2005 - 8:00:00 AM
|
Latest Research
:
Cancer
:
Lung
Diagnostic Strategy May Help Determine Stage Of Lung Cancer More Accurately
A preoperative testing strategy combining two procedures may help improve the accuracy of determining the stage of lung cancer, according to an article in the August 24/31 issue of JAMA.
Aug 24, 2005 - 7:30:00 PM
|
Latest Research
:
Cancer
:
Lung
Nimotuzumab Approved for Non-Small-Cell Lung Cancer Trial
YM BioSciences Inc. , the cancer product development company, today announced that Health Canada has cleared a Clinical Trial Application (CTA) for a multi-center Phase I/II trial utilizing YM's anti-EGFr monoclonal antibody, nimotuzumab (TheraCIM).
Aug 18, 2005 - 11:56:00 AM
|
Latest Research
:
Cancer
:
Lung
Common lung cancer may begin in newly discovered stem cells
The most common form of lung cancer may begin in a group of newly isolated lung stem cells, according to researchers from the Howard Hughes Medical Institute.
Jun 17, 2005 - 3:42:00 AM
|
Latest Research
:
Cancer
:
Lung
First Phase III Study to Extend Median Survival Beyond One Year in Advanced Lung Cancer
Genentech, Inc. (NYSE: DNA) and Roche (SWX Zurich) today announced that data from a Phase III study (E4599) of Avastin (bevacizumab) plus paclitaxel and carboplatin chemotherapies in first-line non-squamous, non-small cell lung cancer (NSCLC) showed the study met its primary efficacy endpoint of improving overall survival.
May 14, 2005 - 7:18:00 AM
|
Latest Research
:
Cancer
:
Lung
:
Small Cell Carcinoma
Survival Not Improved With Dose-Dense Chemotherapy for Small-Cell Lung Cancer
A randomized trial has found that a dose-dense regimen of chemotherapy with blood progenitor cell support did not improve survival compared with standard-dose chemotherapy in patients with small-cell lung cancer (SCLC). However, patients who received the dose-dense regimen had fewer infections and fewer days of treatment than patients who received standard chemotherapy.
May 4, 2005 - 5:26:00 PM
|
Latest Research
:
Cancer
:
Lung
Age not a Limiting Factor in Lung Cancer Therapy
Elderly lung cancer patients tolerate combined chemotherapy and radiotherapy with no higher risk of death than younger patients, according to a new study appearing in the June 1, 2005 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society
Apr 26, 2005 - 2:02:00 AM
|
Latest Research
:
Cancer
:
Lung
Early detection of Lung Cancer
This study was aimed at the detection of lung cancer in its early stages amongst high-risk persons by means of Computerised Axial Tomography (CAT).
Apr 20, 2005 - 8:19:00 PM
|
Latest Research
:
Cancer
:
Lung
Clinical Trial of Gefitinib for Advanced Lung Cancer Closes Early
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
Apr 20, 2005 - 7:23:00 PM
|
Latest Research
:
Cancer
:
Lung
Abnormal lung cancer screening results may help smokers quit
According to a new study, smokers who receive multiple abnormal results using computed tomography (CT) to screen for lung cancer are more likely to quit, suggesting an opportunity for doctors to motivate smokers to quit smoking.
Apr 11, 2005 - 12:41:00 PM
|
Latest Research
:
Cancer
:
Lung
Aerosolized Cyclosporine Shows Significant Results in Chronic Rejection of Allogenic Lung Transplants
The Pulmonary-Allergy Drugs Advisory Committee will review Chirons aerosolized cyclosporine Pulminiq for lung transplantation June 6.
Chiron is seeking approval for use of aerosolized cyclosporine in combination with standard immunosuppressive therapy to increase survival and prevent chronic rejection in patients receiving allogenic lung transplants.
Mar 24, 2005 - 9:22:00 AM
|
Latest Research
:
Cancer
:
Lung
Bevacizumab plus Chemotherapy can Prolong Lung Cancer Survival
Preliminary results from a large, randomized clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those patients who received bevacizumab (AvastinTM) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.
Mar 18, 2005 - 11:41:00 PM
|
Latest Research
:
Cancer
:
Lung
Adding Bevacizumab in First-Line Chemotherapy Regimen Improves Overall Survival in Non-Squamous, Non-Small Cell Lung Cancer
Genentech, Inc. and Roche today announced that an interim analysis of a Phase III study of Avastin(TM)(bevacizumab) plus paclitaxel and carboplatin chemotherapies in first-line non-squamous, non-small cell lung cancer (NSCLC) met its primary efficacy endpoint of improving overall survival, or a reduction in the risk of death, compared to chemotherapy alone.
Mar 15, 2005 - 11:31:00 AM
|
Latest Research
:
Cancer
:
Lung
Women may be more susceptible to lung cancer than men due to estrogen
Since 1930, a 600 percent increase in death rates from lung cancer has been reported in women in the United States, leading some experts to suggest that women may be more susceptible to lung cancer than men. The current research contends that this could be due to the effects of estrogen on the lungs.
Feb 16, 2005 - 7:44:00 PM
|
<< prev
next >>
|
|
|
|
| Health |
Gathering information about food is not top priority for individuals with high metabolisms
|
NIH renews funding for University of Maryland vaccine research
|
DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
|
New IOM report lays out plan to determine effectiveness of obesity prevention efforts
|
Vitamin D supplementation may delay precocious puberty in girls
|
Study: Pedometer program helps motivate participants to sit less, move more
|
Fish oil may stall effects of junk food on brain
|
Intake of low energy dense food better than skipping meals
|
Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
|
Molecular hub links obesity, heart disease to high blood pressure
|
| | Healthcare |
Healthcare experts from UK and India meet at the UK Parliament to discuss ways to improve health care in India, UK
|
Flu pandemic infected one in five
|
Stigma preventing leprosy-cured from getting jobs
|
Measles, Mumps make a comeback in US
|
Melinda Gates calls on Akhilesh Yadav
|
'Movies, TV impact tobacco users more than newspapers'
|
Rockland to open three new hospitals in NCR
|
Spice Global enters healthcare business with hospital in Delhi
|
Delhi to expedite recruitment of doctors
|
India adds spice to US life, keeps it healthy
|
| | Latest Research |
How do consumers see a product when they hear music?
|
Drug activates virus against cancer
|
Bone loss associated with increased production of ROS
|
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
|
Crystal methamphetamine use by street youth increases risk of injecting drugs
|
Johns Hopkins-led study shows increased life expectancy among family caregivers
|
Moderate to severe psoriasis linked to chronic kidney disease, say experts
|
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
|
Simple blood or urine test to identify blinding disease
|
Physician job satisfaction driven by quality of patient care
|
| | Medical News |
NHRC issues notice to Kerala over infant deaths
|
Advanced breast cancer detecting machine comes to India
|
'Dispel myths about vitiligo'
|
NHRC summons Odisha chief secretary
|
Woman dies of swine flu in UP
|
Maharashtra, GE to modernise rural health care
|
Hypertension: India's silent killer
|
Need cautious effort to eradicate polio: Experts
|
Ayurveda experts develop online personalised health regimen
|
Soon a detailed study on 'diabesity': Doctors
|
| | Special Topics |
MPs express anguish at Delhi gang-rape, Shinde assures fast trial
|
Worrying rise in number of medical students in prostitution over last 10 years
|
Behold India's unfolding democratic revolution
|
Chinese woman cuts open her belly to save surgery cost
|
Improved Sense of Smell Produced Smarter Mammals
|
Two-year-old world's first to have extra DNA strand
|
172,155 kidney stones removed from one patient!
|
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
|
|
